Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Terminated 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplasms 2Liver Neoplasms 2Carcinoma 2

Interventions

Sorafenib 61Bevacizumab 42Oxaliplatin 24Doxorubicin 22Radiosurgery 20Gemcitabine 20Fluorouracil 20Nivolumab 19durvalumab 18Radiofrequency Ablation 18pembrolizumab 17Capecitabine 17lenvatinib 16Cisplatin 16atezolizumab 13Leucovorin 13Radiotherapy 11tremelimumab 10Cyclophosphamide 10Carboplatin 10Irinotecan 9Ipilimumab 9Drug Therapy 9Everolimus 8Cryosurgery 8toripalimab 7fludarabine 7Sunitinib 7Chemotherapy, Adjuvant 7Melphalan 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Liver Neoplasms × seocalcitol × Clear all
NCT00051532 2025-02-25

Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma

LEO Pharma

Phase NA Terminated
700 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

NCT00051545 2025-02-25

Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma

LEO Pharma

Phase 3 Terminated
608 enrolled
Gastrointestinal

Carcinoma, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡